Blog
RSS FeedPosted by Michael Wonder on 26 Feb 2026
Clinical equivalence and non-inferiority within health technology assessment
23 February 2026 - Non-inferiority and clinical equivalence clinical trials can be used to determine whether a health technology is no ...
Posted by Michael Wonder on 24 Feb 2026
First treatment for vitiligo recommended by NICE for NHS use, bringing hope to over 80,000 people
24 February 2026 - For the first time, NICE has recommended a medicine that effectively treats the underlying cause of devastating ...
Posted by Michael Wonder on 18 Feb 2026
NICE recommends first ever disease modifying treatment for ARG1 deficiency
17 February 2026 - NICE has recommended the first disease modifying treatment for arginase 1 deficiency (ARG1-D), an ultra-rare, inherited and ...
Posted by Michael Wonder on 28 Jan 2026
New hope for people with breathing condition, COPD, as NICE approves innovative treatment
26 January 2026 - Almost 30,000 people in England with a respiratory disease called COPD (chronic obstructive pulmonary disease) could ...
Posted by Michael Wonder on 26 Jan 2026
Thousands could benefit from new take-at-home treatment for advanced prostate cancer
23 January 2026 - NICE recommends life-extending daily pill which offers hope for people who cannot take standard treatment. ...
Posted by Michael Wonder on 22 Jan 2026
Thousands living with lupus offered hope from twice yearly infusion
22 January 2026 - NICE approves breakthrough combination treatment that restores normal kidney function in almost half of patients with lupus ...
Posted by Michael Wonder on 06 Jan 2026
NICE recommends new treatment option for highly active multiple sclerosis
2 January 2026 - Thousands of people living with a form of multiple sclerosis will benefit from greater treatment choice, following ...
Posted by Michael Wonder on 24 Dec 2025
Thousands more people with advanced bowel cancer to benefit as NICE approves bevacizumab biosimilars
24 December 2025 - More than 7,000 people in England will now be able to access to a life-extending treatment for ...
Posted by Michael Wonder on 12 Dec 2025
Landmark UK-US pharmaceuticals deal to safeguard medicines access and drive vital investment for UK patients and businesses
1 December 2025 - Tens of thousands of NHS patients will benefit from a landmark trade deal between the UK and the ...
Posted by Michael Wonder on 03 Dec 2025
To avoid tariffs, UK agrees to Trump’s demand to pay more for drugs
3 December 2025 - President Trump has complained that wealthy countries like Britain pay too little for drugs, leading America to ...
Posted by Michael Wonder on 01 Dec 2025
Changes to NICE’s cost effectiveness thresholds confirmed
1 December 2025 - The Government has today announced that it will increase the thresholds NICE uses in evaluations of new ...
Posted by Michael Wonder on 27 Nov 2025
MHRA approves inavolisib for the treatment of breast cancer
26 November 2025 - The MHRA has today approved inavolisib (Itovebi) for the treatment of adults with a type of breast ...
Posted by Michael Wonder on 26 Nov 2025
Hundreds could benefit from life saving blood cancer treatment recommended by NICE
25 November 2025 - People with a rare and aggressive blood cancer will benefit from a potentially life saving treatment, following ...
Posted by Michael Wonder on 26 Nov 2025
UK set to raise prices of drugs in US agreement
23 November 2025 - The UK Government is in the late stages of agreeing a major drug pricing deal with ...
Posted by Michael Wonder on 21 Nov 2025
Alnylam's ATTR cardiomyopathy drug backed for NHS use
21 November 2025 - Patients in England and Wales with cardiomyopathy caused by the disorder ATTR amyloidosis will soon be ...